Aug 20, 2026 · 31 min
Moderna advances personalized cancer vaccines as delivery and debt pressures mount
Did Moderna Just Cure Cancer? & Freight Trains Have a $200M Theft Problem
The episode connects a potentially important medical advance with the operational, financial, and environmental strains reshaping everyday business.
- 1Moderna’s personalized mRNA vaccine showed encouraging melanoma results, but scalability, cost, and long-term cancer ambitions remain unresolved.
- 2Amazon and rivals see drones as a faster delivery network, while noise, safety, and neighborhood opposition threaten adoption.
- 3Blue Apron’s collapse, rising train theft, and $40 trillion in US debt reflect broader pressure across supply chains and institutions.
Don't miss
The episode’s most striking turn comes when Liquid Death and Garage Beer answer data centers’ water consumption with a deliberately absurd urine-donation campaign.
The brief
Neal Freiman and Raymond Liu open with the frenzy around Dune Part 3 tickets, then pivot to Moderna’s personalized mRNA cancer vaccine and its late-stage melanoma results.
Moderna’s vaccine is customized to tumor mutations with AI and paired with Merck’s Keytruda, but the promise raises difficult questions about cost, scale, and cancer’s commercial future.
Amazon, Uber, and other companies are racing toward drone delivery, even as noise, falling objects, and resistance to crowded residential skies challenge the business case.
Blue Apron’s decline traces the meal-kit industry’s fragility through supplier trouble, a sale at a much lower valuation, and its transition to Misfits Market.
Neil’s Numbers turns to freight theft, millennial incomes, and recruiter responsiveness before the episode closes on $40 trillion in US debt and Liquid Death’s data-center water campaign.
Featuring
Mentioned
The OdysseyBooks & mentions
Listen to the full episode and explore every guest, topic, and moment on PodLume.